Overall survival or other clinical benefits from adjuvant selective intraarterial chemotherapy in patients undergoing curative liver resection for metastatic colorectal tumor
- PMID: 10522730
- PMCID: PMC1420909
- DOI: 10.1097/00000658-199910000-00016
Overall survival or other clinical benefits from adjuvant selective intraarterial chemotherapy in patients undergoing curative liver resection for metastatic colorectal tumor
Comment on
-
Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).Ann Surg. 1998 Dec;228(6):756-62. doi: 10.1097/00000658-199812000-00006. Ann Surg. 1998. PMID: 9860474 Free PMC article. Clinical Trial.
References
-
- Fong Y, Kemeny N, Paty P, et al. Treatment of colorectal cancer:: hepatic metastases. Semin Surg Oncol 1996; 12: 219–252. - PubMed
-
- Nonami T, Takeuchi Y, Yasui M, et al. Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma. Semin Oncol 1997; 24: S6–130–S6–134. - PubMed
-
- Selzner M, Clavien PA. Resection of liver tumors. In: Clavien P, ed. Primary and secondary liver tumors: current and emerging therapies. Durham: Blackwell Science; 1999: 137–149.
-
- Ensminger W, Rosowsky AR, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusion of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 1978; 38: 3784–3792. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
